Skip to content

Contralesional Plantar Peripheral Electrical Stimulation Combined with Contralesional Posterior Parietal Cortex Repetitive Transcranial Magnetic Stimulation Promotes Lower-Limb Motor Recovery in Stroke Patients with Hemiparesis: A Randomized, Double-Blind, Factorial Controlled Trial

Contralesional Plantar Peripheral Electrical Stimulation Combined with Contralesional Posterior Parietal Cortex Repetitive Transcranial Magnetic Stimulation Promotes Lower-Limb Motor Recovery in Stroke Patients with Hemiparesis: A Randomized, Double-Blind, Factorial Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123624
Enrollment
Unknown
Registered
2026-04-28
Start date
2024-09-22
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Double-sham control group:Conventional rehabilitation (TAU) + sham contralesional plantar sensory electrical stimulation (PES) + sham contralesional PPC-TMS
Active PES + sham PPC-TMS group:TAU + active contralesional plantar PES + sham PPC-TMS
Active PPC-TMS + sham PES group:TAU + sham contralesional plantar PES + active contralesional PPC-TMS (iTBS)
Combined active PES + active PPC-TMS group:TAU + active contralesional plantar PES + active contralesional PPC-TMS (iTBS)

Sponsors

Xinjiang Uyghur Autonomous Region Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 80 years, any gender; 2. Imaging-confirmed stroke (ischemic/hemorrhagic) with unilateral hemiplegia; 3. Time since onset between 2 weeks and 6 months; 4. Stable vital signs, able to understand and cooperate with the assessment and training; 5. Voluntary participation and signed written informed consent.

Exclusion criteria

Exclusion criteria: 1. Contraindications to TMS: history of epilepsy or high risk of seizures, intracranial metal foreign bodies/implanted electronic devices, cardiac pacemaker or other implanted stimulators, etc.; 2. Unstable vital signs or severe medical complications that may preclude completion of the treatment course; 3. Skin damage, infection, severe pain, or significant sensory abnormalities on the plantar surface of the non-paretic foot, making electrical stimulation intolerable or unsuitable; 4. Severe cognitive impairment, mental disorders, or significant aphasia that prevents cooperation with assessment and training; 5. Planned or ongoing receipt of other intensive neuromodulation therapies during the study period, where the dosage/frequency cannot be controlled.

Design outcomes

Primary

MeasureTime frame
Change in Fugl–Meyer Assessment–Lower Extremity (FMA-LE) score;

Secondary

MeasureTime frame
Change in Postural Assessment Scale for Stroke (PASS) score;Change in Berg Balance Scale (BBS) score;Change in Modified Barthel Index (MBI; lower-limb related) score;3D gait analysis: Change in peak knee flexion angle on the affected side;

Countries

China

Contacts

Public ContactRong Bian

Xinjiang Uyghur Autonomous Region Hospital of Traditional Chinese Medicine

bian9056rong@163.com+86 157 7180 5120

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026